Home / Health / Company's quest for antibody drug against Covid has it 'jumping out of joy'

Company's quest for antibody drug against Covid has it 'jumping out of joy'

Regeneron's two-antibody drug is unique: One came from a Covid-19 survivor in Singapore and the other from the company's genetically modified mice

Premium

Members of the Regeneron's infectious disease team pose for a photo as they celebrate their first discovery of potential antibodies to treat Covid-19. Photo: AP

AP | PTI

9 min read Last Updated : Dec 21 2020 | 2:37 PM IST

On a Saturday afternoon in March as Covid-19 was bearing down on New York City, a dozen scientists anxiously crowded around a computer in a suburban drug company’s lab. They had spent weeks frantically getting blood from early survivors across the globe and from mice with human-like immune systems — all to test thousands of potential treatments.

Now it was time for results.

The screen flashed totals of glowing green dots, hundreds or thousands in most samples. Then they saw some 10s, some twos and finally, zeroes.

The researchers cheered and their boss sent out for champagne.

No dots meant no infected cells. The

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in